OR WAIT 15 SECS
Heather Onorati is the Channel Content Director for Dermatology Times and Cosmetic Surgery Times.
Merz announced the launch of Belotero Revive, Friday, April 5, in selected countries in Europe and Latin America. The new “beauty booster” is designed to improve hydration, elasticity and skin firmness with a combination of hyaluronic acid and glycerol. It is injected beneath the skin to reduce the appearance of fine lines, or as an early intervention treatment, to slow the progression of facial aging, the company says.
“Strong scientific research forms the basis for this new dermal injectable and our study results show that treatment with this beauty booster is an effective way to provide direct skin hydration and increase skin smoothness, giving our patients beautiful, natural-looking results,” said Prof. Dr. Martina Kerscher, Professor of Dermatology, University of Hamburg and lead author of the BELOVE study.
In a clinical study, 24 patients received injections in the lower cheek area of the face and were observed over a 36-week period. Patients saw a gradual reduction in redness over 36 weeks and noticed improved skin hydration after one week of treatment, which continued to improve up to week 36. All 24 patients noted improvement at 12 weeks and 80% were satisfied with treatment at week 24.
According to the company, Belotero Revive targets a new generation of aesthetic patients who are focused on addressing early signs of aging. The product will be launched within additional markets later this year.